Eleonora Teplinsky
Impact in
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Co-authors
- Franco M. Muggia (5 shared papers)Francisco J. Esteva (3 shared papers)Thomas J. Herzog (1 shared paper)Komal L. Jhaveri (3 shared papers)Shilpi Gupta (1 shared paper)Sara Beltrán Ponce (3 shared papers)Prarthna V Bhardwaj (1 shared paper)Deanna Gek Koon Teoh (1 shared paper)
- Journals
- JCO Oncology Practice (3 papers)Journal of Clinical Oncology (3 papers)Clinical Breast Cancer (3 papers)Breast Cancer Research and Treatment (2 papers)Current Oncology Reports (2 papers)
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Eleonora Teplinsky
22 papers receiving 646 citations
Eleonora Teplinsky's Hit Papers
Peers
Comparison fields: 5 of 72
- Obstetrics and Gynecology 150
- Reproductive Medicine 94
- Oncology 221
- Cancer Research 60
- Immunology 53
Countries citing papers authored by Eleonora Teplinsky
This map shows the geographic impact of Eleonora Teplinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Teplinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Teplinsky more than expected).
Fields of papers citing papers by Eleonora Teplinsky
This network shows the impact of papers produced by Eleonora Teplinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Teplinsky. The network helps show where Eleonora Teplinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Eleonora Teplinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial Hit paper breakdown → | 2023 | 230 |
| 2 | 2020 | 74 | |
| 3 | 2014 | 58 | |
| 4 | 2015 | 55 | |
| 5 | 2017 | 52 | |
| 6 | 2022 | 41 | |
| 7 | 2017 | 29 | |
| 8 | 2024 | 22 | |
| 9 | 2013 | 18 | |
| 10 | 2017 | 18 | |
| 11 | 2020 | 15 | |
| 12 | 2016 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2015 | 7 | |
| 15 | 2024 | 6 | |
| 16 | 2023 | 2 | |
| 17 | 2015 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 1 |
About Eleonora Teplinsky
Eleonora Teplinsky is a scholar working on Oncology, Health, Reproductive Medicine, Pulmonary and Respiratory Medicine and Sociology and Political Science, having authored 27 papers that have together received 659 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), HER2/EGFR in Cancer Research (4 papers), Social Media in Health Education (4 papers), Family Support in Illness (3 papers), Economic and Financial Impacts of Cancer (3 papers), Cancer survivorship and care (3 papers), Lung Cancer Research Studies (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Obstetrics and Gynecology (150 citations), Reproductive Medicine (94 citations), Oncology (221 citations), Cancer Research (60 citations) and Immunology (53 citations). Eleonora Teplinsky has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Franco M. Muggia, Francisco J. Esteva, Thomas J. Herzog, Komal L. Jhaveri, Shilpi Gupta, Sara Beltrán Ponce, Prarthna V Bhardwaj, Deanna Gek Koon Teoh, Emily K. Drake and Kent P Friedman. Their work appears in journals such as JCO Oncology Practice, Journal of Clinical Oncology, Clinical Breast Cancer, Breast Cancer Research and Treatment and Current Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.